Stanley H. Appel MD

Company: Houston Methodist Research Institute / Coya Therapeutics

Job title: Chair & Scientific Advisory Board

Seminars:

Learning from Smaller Scale Studies to Plan Effectively for Phase 3 Trials, Using Learnings From ALS 11:00 am

Utilizing biomarkers to characterize Treg response and impact on disease progression Leveraging data to optimize dosage frequency and timing in treatment paradigm to have the most therapeutic impact Presenting phase II trial data and discussing later stage trial development to optimize efficacy in large populations of ALS patientsRead more

day: Day One